Peptide Therapeutics intermediate
Milestone 008: Oligopeptide Research Reference
1993: First GLP-1 agonist (exenatide) discovered from Gila monster venom. Opens incretin therapy. This peptide or oligopeptide is studied for its biological ...
By Encyclopeptide Editorial | 1 min read
milestone-008 peptide research
Overview
1993: First GLP-1 agonist (exenatide) discovered from Gila monster venom. Opens incretin therapy.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Milestone 008” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Milestone 008: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept